Galera Therapeutics fetches $15 mln

Malvern, Pennsylvania-based Galera Therapeutics Inc, a biotech firm that is developing new treatments for cancer patients, has secured $15 million in funding. The investor was Sofinnova Ventures.

29 November 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail